Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to ...

As part of celebrating WWMT's 75th birthday, we're catching up with some of the people who have been part of television ...

We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ ...

From a valuation standpoint, Pfizer appears attractive relative to the industry and is trading below its 5-year mean. Going ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

AbbVie ABBV has built a substantial oncology franchise. Initially anchored by blood cancer drugs Imbruvica and Venclexta, the ...

Ahmedabad: CORONA Remedies Limited, backed by Sepia Investments Limited, an affiliate of ChrysCapital, has appointed ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

Total construction starts were up 13% in May to a seasonally adjusted annual rate of $1.16 trillion, according to Dodge ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

India's pharma sector is poised for innovation-led growth, fueled by patent expirations and government support. The ₹5,000-cr ...